What is the recommended treatment for strep throat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Strep Throat

Penicillin or amoxicillin for 10 days is the definitive first-line treatment for strep throat due to proven efficacy, narrow spectrum, complete absence of resistance, safety profile, and low cost. 1, 2

Diagnostic Confirmation Before Treatment

  • Test patients with 2 or more Centor criteria (fever, tonsillar exudates, tender anterior cervical lymphadenopathy, absence of cough) using rapid antigen detection test (RADT) or throat culture before initiating antibiotics 1, 2
  • Children under 3 years generally do not require testing unless specific risk factors exist, such as an older sibling with strep infection 1, 2
  • Diagnostic testing is not recommended if clinical features strongly suggest viral etiology (cough, rhinorrhea, hoarseness, oral ulcers) 1

First-Line Antibiotic Regimens for Non-Allergic Patients

Penicillin V (oral):

  • Adults: 500 mg twice daily for 10 days 1, 2
  • Children: 250 mg twice daily or three times daily for 10 days 1, 2

Amoxicillin (oral) - equally effective and more palatable:

  • Adults and children ≥40 kg: 500 mg twice daily for 10 days 1, 3
  • Children <40 kg: 25 mg/kg/day divided twice daily (or 50 mg/kg once daily, maximum 1000 mg) for 10 days 1, 3
  • Amoxicillin is often preferred in young children due to better taste acceptance 1, 4

Intramuscular benzathine penicillin G:

  • <27 kg (60 lb): 600,000 units as single dose 1
  • ≥27 kg: 1,200,000 units as single dose 1
  • Reserved for patients with questionable adherence to oral therapy 1, 2

Treatment for Penicillin-Allergic Patients

Non-Immediate/Non-Anaphylactic Penicillin Allergy

First-generation cephalosporins are the preferred alternatives (cross-reactivity risk only 0.1% in non-severe reactions) 5, 2:

  • Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 1, 5
  • Cefadroxil: 30 mg/kg once daily (maximum 1 gram) for 10 days 1, 5

Immediate/Anaphylactic Penicillin Allergy

Avoid all beta-lactams including cephalosporins due to up to 10% cross-reactivity risk 1, 5, 2

Clindamycin is the preferred choice:

  • 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days 1, 5
  • Approximately 1% resistance rate in the United States 1, 5, 2
  • Particularly effective for chronic carriers and difficult-to-eradicate infections 5, 6

Macrolides are acceptable alternatives but have higher resistance:

  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days 1, 5
  • Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 1, 5
  • Macrolide resistance is approximately 5-8% in the United States and varies geographically 1, 5, 2

Critical Treatment Duration Requirements

A full 10-day course is mandatory for all antibiotics except azithromycin to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever 1, 2. Azithromycin requires only 5 days due to its prolonged tissue half-life and unique pharmacokinetics 1, 5, 2.

Adjunctive Symptomatic Treatment

  • Acetaminophen or NSAIDs (ibuprofen) should be considered for moderate to severe symptoms or high fever 1, 5
  • Aspirin must be avoided in children due to risk of Reye syndrome 1, 5, 2
  • Corticosteroids are not recommended as adjunctive therapy 1, 5, 2

Special Clinical Situations

Concurrent infectious mononucleosis:

  • Avoid ampicillin and amoxicillin due to high risk of severe rash (up to 90%) 6
  • Use first-generation cephalosporin (cephalexin or cefadroxil), clindamycin, or erythromycin if antibiotic treatment is indicated for documented Group A streptococcal infection 6

Recurrent pharyngitis:

  • Distinguish between true recurrent infections versus chronic carrier experiencing viral infections 1, 2
  • Chronic carriers generally do not require treatment as they are unlikely to spread infection or develop complications 1, 5
  • For documented recurrent infections with treatment failures, consider clindamycin or amoxicillin-clavulanate 2

Pregnancy:

  • Penicillin and amoxicillin remain first-line with proven safety 2
  • For penicillin-allergic pregnant patients, use cephalexin/cefadroxil for non-anaphylactic allergy or clindamycin for anaphylactic allergy 2

Common Pitfalls to Avoid

  • Do not prescribe shorter courses than recommended (except azithromycin's 5-day regimen) as this increases treatment failure rates and risk of acute rheumatic fever 1, 5, 2
  • Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to 10% cross-reactivity risk 1, 5, 2
  • Do not use tetracyclines due to high prevalence of resistant strains 1
  • Do not use sulfonamides or trimethoprim-sulfamethoxazole as they do not eradicate Group A Streptococcus 1, 5
  • Do not use older fluoroquinolones (ciprofloxacin) as they have limited activity against Group A Streptococcus 1
  • Check local macrolide resistance patterns before prescribing azithromycin or clarithromycin, as resistance varies geographically and can lead to treatment failure 5, 2
  • Do not routinely perform follow-up throat cultures in asymptomatic patients who have completed therapy 1, 6, 2

When to Reevaluate

Patients with worsening symptoms after appropriate antibiotic initiation or with symptoms lasting 5 days after the start of treatment should be reevaluated 7. Patients become non-contagious after 24 hours of appropriate antibiotic therapy 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of streptococcal pharyngitis.

American family physician, 2009

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Concurrent Strep Pharyngitis and Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Streptococcal Pharyngitis: Rapid Evidence Review.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.